Cold & Cough Remedies (Pharmacies) - Egypt

  • Egypt
  • Revenue in the Cold & Cough Remedies market is projected to reach US$0.30bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 10.76%, resulting in a market volume of US$0.50bn by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.62 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Egypt has been experiencing steady growth in recent years.

Customer preferences:
Egyptian consumers have shown a strong preference for over-the-counter cold and cough remedies purchased from pharmacies. This is due to the convenience and accessibility of pharmacies, which are widely available throughout the country. Consumers value the ability to easily obtain these remedies without needing a prescription, allowing them to quickly and effectively manage their symptoms.

Trends in the market:
One major trend in the Cold & Cough Remedies market in Egypt is the increasing demand for natural and herbal remedies. Egyptian consumers are becoming more health-conscious and are seeking products with natural ingredients. This trend is driven by a desire for safer and gentler remedies, as well as a growing preference for traditional and alternative medicine. Another trend in the market is the rise of combination products. Cold and cough remedies that offer multiple benefits, such as relieving congestion and soothing sore throats, are gaining popularity among Egyptian consumers. These combination products provide convenience and cost-effectiveness, as they address multiple symptoms with a single product.

Local special circumstances:
Egypt has a high prevalence of respiratory infections, which contributes to the demand for cold and cough remedies. The country's large population and crowded urban areas make it more susceptible to the spread of respiratory illnesses. Additionally, Egypt experiences seasonal changes that can lead to increased incidence of colds and coughs.

Underlying macroeconomic factors:
The growing middle class in Egypt has contributed to the expansion of the Cold & Cough Remedies market. As more people have disposable income, they are able to afford these products and prioritize their health and well-being. Additionally, the increasing urbanization in Egypt has led to a higher demand for convenient healthcare solutions, including over-the-counter remedies available in pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Egypt is developing due to the preferences of Egyptian consumers for over-the-counter remedies purchased from pharmacies, the increasing demand for natural and herbal remedies, and the rise of combination products. The local special circumstances, such as the high prevalence of respiratory infections and seasonal changes, further contribute to the market's growth. The underlying macroeconomic factors, including the growing middle class and urbanization, also play a significant role in the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)